Donor-origin anaplastic lymphoma kinase driver-positive inflammatory myofibroblastic tumor after umbilical cord blood transplantation in pediatric acute lymphoblastic leukemia
Ayumi Horiguchi
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorCorresponding Author
Yuki Arakawa
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Correspondence
Yuki Arakawa, Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan, 1-2, Shintoshin, Chuo-ku, Saitama 330-8777, Japan.
Email: [email protected]
Search for more papers by this authorJun Noguchi
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorMakiko Mori
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorKoichi Oshima
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorItaru Iwama
Department of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorHiroshi Kawashima
Department of Surgery, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorYutaka Tanami
Department of Radiology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorAtsuko Nakazawa
Department of Clinical Research, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorKatsuyoshi Koh
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorAyumi Horiguchi
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorCorresponding Author
Yuki Arakawa
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Correspondence
Yuki Arakawa, Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan, 1-2, Shintoshin, Chuo-ku, Saitama 330-8777, Japan.
Email: [email protected]
Search for more papers by this authorJun Noguchi
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorMakiko Mori
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorKoichi Oshima
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorItaru Iwama
Department of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorHiroshi Kawashima
Department of Surgery, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorYutaka Tanami
Department of Radiology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorAtsuko Nakazawa
Department of Clinical Research, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorKatsuyoshi Koh
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this author
REFERENCES
- 1Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995; 19(8): 859-872.
- 2Karnak I, Senocak ME, Ciftci AO, et al. Inflammatory myofibroblastic tumor in children: diagnosis and treatment. J Pediatr Surg. 2001; 36(6): 908-912.
- 3Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007; 31(4): 509-520.
- 4Bahat G, Kalayoglu-Besisik S, Ozturk S, Kilicaslan I, Tunc M, Sargin D. Inflammatory pseudotumor following hematopoietic stem cell transplantation: a new case and review of the literature. Bone Marrow Transplant. 2007; 40(10): 915-918.
- 5Fangusaro J, Klopfenstein K, Groner J, Hammond S, Altura RA. Inflammatory myofibroblastic tumor following hematopoietic stem cell transplantation: report of two pediatric cases. Bone Marrow Transplant. 2004; 33(1): 103-107.
- 6Fujino H, Park YD, Uemura S, et al. An endobronchial inflammatory myofibroblastic tumor in a 10-yr-old child after allogeneic hematopoietic cell transplantation. Pediatr Transplant. 2014; 18(5): E165-E168.
- 7Nomura S, Ishii K, Shimizu M, Inami N, Urase F, Maeda Y. Inflammatory pseudotumor following cord blood transplantation for adult T-cell leukemia. Bone Marrow Transplant. 2008; 42(7): 493-494.
- 8Ogura K, Ikeda T, Kobayashi S, et al. Inflammatory pseudotumor of the kidney arising after unrelated bone marrow transplantation. Bone Marrow Transplant. 2004; 34(9): 831-832.
- 9Priebe-Richter C, Ivanyi P, Buer J, et al. Inflammatory pseudotumor of the lung following invasive aspergillosis in a patient with chronic graft-vs.-host disease. Eur J Haematol. 2005; 75(1): 68-72.
- 10Shash H, Stefanovici C, Phillips S, Cuvelier GD. Aggressive metastatic inflammatory myofibroblastic tumor after allogeneic stem cell transplant with fatal pulmonary toxicity from crizotinib. J Pediatr Hematol Oncol. 2016; 38(8): 642-645.
- 11Tsutsumi Y, Kanamori H, Kawamura T, et al. Inflammatory pseudotumor of the brain following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2005; 35(11): 1123-1124.
- 12Vroobel K, Judson I, Dainton M, McCormick A, Fisher C, Thway K. ALK-positive inflammatory myofibroblastic tumor harboring ALK gene rearrangement, occurring after allogeneic stem cell transplant in an adult male. Pathol Res Pract. 2016; 212(8): 743-746.
- 13Tufan A, Bahat G. Inflammatory pseudotumors after stem cell transplantation. Hematol Rep. 2015; 7(3): 5848.
- 14Koh K, Kato M, Saito AM, et al. Phase II/III study in children and adolescents with newly diagnosed B-cell precursor acute lymphoblastic leukemia: protocol for a nationwide multicenter trial in Japan. Jpn J Clin Oncol. 2018; 48(7): 684-691.
- 15Ades L, Guardiola P, Socie G. Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems. Blood Rev. 2002; 16(2): 135-146.
- 16Worthley DL, Ruszkiewicz A, Davies R, et al. Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-origin cells following allogeneic stem cell transplantation. Stem Cells. 2009; 27(6): 1463-1468.
- 17Ogawa M, LaRue AC, Drake CJ. Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications. Blood. 2006; 108: 2893-2896.
- 18Shirai K, Sera Y, Bulkeley W, et al. Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia. Exp Hematol. 2009; 37(12): 1464-1471.
- 19Malgirei A, Kantzari E, Patrizi MP, Dambadella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med. 2010; 3(4): 248-269.
